You are here
Consultations
We conduct public consultations as part of our broader stakeholder engagement work, including on changes to regulatory requirements or practices, reviews of business processes, standards or guidelines, and TGA fees and charges.
Filters
Status
Categories
- Advertising (2) Apply Advertising filter
- Australian Register of Therapeutic Goods (ARTG) (1) Apply Australian Register of Therapeutic Goods (ARTG) filter
- Biologicals (2) Apply Biologicals filter
- Remove Blood and blood components filter Blood and blood components (0)
- Complementary medicines (7) Apply Complementary medicines filter
- Fees/Payments (1) Apply Fees/Payments filter
- Import/Export (1) Apply Import/Export filter
- Labelling/Packaging (1) Apply Labelling/Packaging filter
- Legislation (3) Apply Legislation filter
- Listed medicines (2) Apply Listed medicines filter
- Remove Manufacturing filter Manufacturing (0)
- Remove Medical devices/IVDs filter Medical devices/IVDs (55)
- Medical devices safety (1) Apply Medical devices safety filter
- Medicines (2) Apply Medicines filter
- Medicines safety (1) Apply Medicines safety filter
- OTC medicines (12) Apply OTC medicines filter
- Other therapeutic goods (1) Apply Other therapeutic goods filter
- Prescription medicines (5) Apply Prescription medicines filter
- Remove Safety of medicines & medical devices filter Safety of medicines & medical devices (0)
- Remove Scheduling filter Scheduling (55)
- Therapeutic Goods Administration (TGA) (2) Apply Therapeutic Goods Administration (TGA) filter
- Therapeutic goods regulation (2) Apply Therapeutic goods regulation filter
- (-) Remove Safety of medicines & medical devices filter Safety of medicines & medical devices
- (-) Remove Blood and blood components filter Blood and blood components
- (-) Remove Medical devices/IVDs filter Medical devices/IVDs
- (-) Remove Manufacturing filter Manufacturing
- (-) Remove Scheduling filter Scheduling
Comparable overseas regulators - medical devices
Closed on 30 June 2017
Proposed Amendments to the Poisons Standard - ACCS, ACMS and Joint ACCS/ACMS meetings, July 2017
Closed on 15 June 2017
The Scheduling Policy Framework and Advertising of Pharmacist-only medicines (Schedule 3 substances)
Closed on 28 April 2017
Designation of Australian conformity assessment bodies for medical devices - Implementation
Closed on 11 January 2017
Accelerated assessment of medical devices - Priority Review pathway - Implementation
Closed on 11 January 2017
Software as a Medical Device (SaMD): Clinical Evaluation
Closed on 2 December 2016
Proposed Amendments to the Poisons Standard - ACCS and ACMS meetings, November 2016
Closed on 20 October 2016
Proposed Amendments to the Poisons Standard - Joint ACCS and ACMS meeting, November 2016
Closed on 20 October 2016
Proposed amendments to the Poisons Standard - ACCS and Joint ACCS/ACMS, July 2016
Closed on 24 June 2016
Draft clinical evidence guidelines - Medical devices
Closed on 10 June 2016